Smith & Nephew plc (SN1N)
BMV
Real-time Data
02:30 PM
Day's Range
256.5552 wk Range
256.55Overview - SN1N - Smith & Nephew plc
Key Statistics
Valuation
Enterprise Value
4.02T
P/E (Trailing)
‪29.79‬
PEG Ratio
‪-26.96‬
Price / Sales (TTM)
‪34.08‬
Price / Book
‪2.37‬
EV / EBITDA
‪160.19‬
Profitability
Gross Margin
‪75.26%‬
Profit Margin
‪10.07%‬
Operating Margin
‪14.46%‬
Return on Assets
‪5.15%‬
Return on Equity
‪11.85%‬
Ownership
Shares Outstanding
849.36M
Float
842.19M
Held by Insiders
‪0.23%‬
Held by Institutions
‪74.82%‬
Price stats
Beta
‪0.68‬
50-Day Avg
‪256.55‬
200-Day Avg
‪256.55‬
Dividends
Payout Ratio
‪53.20%‬
Frequency
Semi-Annual
Market Cap - SN1N - Smith & Nephew plc
Peers - SN1N - Smith & Nephew plc
Peer Comparison
Compared with companies in Medical Devices listed on BMV.
Profile Summary - SN1N - Smith & Nephew plc
About
Smith & Nephew plc is a British multinational medical technology company specializing in the repair, regeneration, and replacement of soft and hard tissue. Headquartered in Watford, England, it develops and manufactures advanced products across three core business units: Advanced Wound Management for treating chronic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
